alexa Reset Osmostat in an Infant with Failure to Thrive | OMICS International
ISSN: 2161-0959
Journal of Nephrology & Therapeutics
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Reset Osmostat in an Infant with Failure to Thrive

Mohammad Ilyas* and Asad Tolaymat

Pediatric Nephrology, University of Florida/Jacksonville, Florida, USA

*Corresponding Author:
Mohammad Ilyas
Clinical Assistant Professor
Pediatric Nephrology
University of Florida/Jacksonville
841 Prudential Drives Suite # 1900
Jacksonville, Florida 32207, USA
Tel: 904 633 0920
Fax: 904 633 0921
E-mail: [email protected]

Received Date: March 27, 2014; Accepted Date: May 10, 2014; Published Date: May 16, 2014

Citation: Ilyas M, Tolaymat A (2014) Reset Osmostat in an Infant with Failure to Thrive. J Nephrol Ther 4:165. doi:10.4172/2161-0959.1000165

Copyright: © 2014 Ilyas M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nephrology & Therapeutics

Abstract

We are reporting an infant who was presented to our institution exhibiting a failure to thrive and hyponatremia. An extensive renal evaluation revealed resistive hyponatremia with normal renal glomerular and tubular function. Patient remained hyponatremic even after fluid restriction, salt loading and Fludrocortisone (Florinef) administration. Water deprivation and water loading tests were suggestive of “hyponatremia of reset osmostat”. The infant had no congenital midline defect.

Keywords

Resistive hyponatremia; Reset osmostat; Failure to thrive

Introduction

Hyponatremia is an important and common electrolyte abnormality usually seen in pediatric inpatients as an isolated finding or as a complication of other medical illnesses. Osmostat is the regulatory center at the hypothalamus that controls the osmolality of the extracellular fluid. Serum sodium concentration and serum osmolarity normally are maintained under precise control via hypothalamic osmo-receptors involving stimulation of thirst, secretion of antidiuretic hormone (ADH), and renal handling of filtered sodium [1]. Hyponatremia is frequently attributed to the syndrome of inappropriate antidiuretic hormone (SIADH). In this condition, despite a low serum sodium and mild volume expansion, the persistent presence of ADH results in concentrated urine (i.e. urine osmolality is higher than plasma osmolality) with a relatively large quantity of sodium. In chronic hyponatremia of reset osmostat, salt and water intake is appropriate but the osmotic threshold for the production and inhibition of ADH occurs at lower level [2]. We are reporting an infant who presented with failure to thrive and euvolemic hyponatremia due to a low set osmostat.

Case Report

A six-month-old white male was the product of a full-term uneventful pregnancy, no polyhydramnios, oligohydramnios or congenital defects. He was delivered vaginally with a birth weight of 3.0 kilograms. He was first admitted to a local hospital at two weeks of age with jaundice and low serum sodium (Na 122 mEq/L). He had no gastrointestinal symptoms of diarrhea or vomiting. He had no underlying cardiovascular, respiratory and neurological symptoms. He had poor weight gain despite receiving adequate calories of about 110 Cal/kg/day. At the age of six weeks, he was readmitted with the concern of failure to thrive. Otherwise, he had no medical symptoms and normal oral intake. His physical examination revealed awake, alert and active, but both height and weight were below 5th percentile for his age. His vital signs were normal; he was normotensive and had no tachypnea, tachycardia or fever. He was normocephalic with anterior fontanel open and flat, no facial dysmorphic features but appears small for age. He has no physical evidence of edema or dehydration. His ears, nose, throat, respiratory, cardiovascular, gastrointestinal, neurological, genitourinary and musculoskeletal exams were all within the normal limits. His developmental milestones were appropriate for his age. Although his formula was increased to a 24-calorie (i.e. 120 Cal/kg/day), he still failed to gain weight. At the age of six months, his weight was 5.2 kilogram (i.e. below 5th percentile) and height was 58 centimeters (i.e. below 5th percentile). His detailed laboratories studies are shown in Table 1. His renal ultrasound and brain MRI were both normal.

Serum Patients Range Normal Values
Sodium 122-130 mEq/L 135-151 mEq/L
Potassium 4.0-5.8 mEq/L 3.2-5.9 mEq/L
Chloride 93-99 mEq/L 98-110 mEq/L
HCO3 18-23 mEq/L 20-27 mEq/L
BUN 10-20 mg/dl 5-18 mg/dl
Creatinine 0.2-0.3 mg/dl 0.2-0.4 mg/dl
Glucose 50-92 mg/dl 50-99 mg/dl
Calcium 10.5 mg/dl 8.9-10.8 mg/dl
PO4 5.1 mg/dl 4.5-6.4 mg/dl
Osmolality 272-277mOm/Kg 275-295mOm/Kg
Alkaline Phosphatase 191 IU/L 20-150 IU/L
Uric Acid 4.6 mg/dl 2.5-5.5 mg/dl
TSH 4.1 ng/dl 3-18 ng/dl
T4 1.4 ng/dl 0.8-2.4 ng/dl
ACTH <10pg/ml 25-100pg/ml
Renin 3.26 ng/ml/hr 2.9-24 ng/ml/hr
Aldosterone 33.9 ng/dl 1-160 ng/dl

Table 1: The pertinent laboratories values

Special studies for workup of hyponatremia

To clarify the mechanism responsible for hyponatremia, we performed several physiological studies including a water deprivation, water loading, salt loading and Fludrocortisone challenge tests. The study results are discussed below and summarized in Table 2.

  Water deprivation Water loading Salt loading Florinef challenge
Before After Before After Before After Before After
Serum Na (mEq/L) 125 129 127 128 125 133 124 127
Serum Osmolality (mEq/L) 269 277 263 270 272 276 268 269
Urine flow rate (ml/min) 0.44 0.01 0.2 0.95 0.2 0.04 -  
Urine osmolality (mOs/kg,) 128 576 283 59 323 586 223 382
Fe Na (%) 0.52 0.13 0.5 0.2 0.25 0.65 0.67 0.24
Water clearance (ml/min) - 0.57 - 1.05 -0.13 0.74 0.78 0.13 -  

Table 2: The results of different tests are summarized in this table

Water deprivation test

A nine hour water deprivation resulted in a 3.6% weight loss. The urine flow declined and the free water clearance diminished. The patient was able to concentrate urine to a level of 576 milliosmoles. His serum sodium remained at 129 mEq/L.

Water loading test

The patient was given a standard water-loading test of D5W 20 ml/kg IV over 30 minutes. The patient excreted the infused water over 4 hours. He was able to dilute the urine to 58 milliosmoles per kilogram although his serum sodium persisted at 128 mEq/L.

Salt loading test

Intravenous 3% saline (0.513 mEq Na/ml) was infused at a rate of 0.2 ml/kg/min for 30 minutes (3 mEq/kg). A transient increase in serum sodium from 125 mEq/L to 133 mEq/L was observed following the infusion. Water clearance and urine flow decreased, and the urine osmolality and fractional excretion of sodium increased.

Fludrocortisone challenge test

Fludrocortisone 50 mcg was given orally. It had a minimal effect on serum sodium and serum osmolality level. Fractional excretion of sodium decreased from a baseline of 0.67% to 0.24%.

Genetic testing

Single gene test for AVPR2 DNA sequence testing was performed at Athena Diagnostics, which showed a sequence of unknown significance for Nephrogenic Diabetes Insipidus (NDI). The sequence variant profile found does not allow any conclusion as to whether the patient is affected with NDI; because significance of one or more variants in AVPR2 for NDI remains unknown.

Discussion

Sodium is a predominant extracellular cation and cannot freely cross the cell membrane. Its homeostasis is vital to the normal physiologic function of cells. Hyponatremia is defined as a serum sodium level of less than 135 mEq/L and is considered severe when the serum sodium level is below 125 mEq/L. Hyponatremia is a known cause of growth failure in infancy as well as beyond neonatal period probably into adulthood. Sodium (Na) is an important growth factor, stimulating cell proliferation and protein synthesis and increasing cell mass. Sodium chloride (NaCl) deprivation inhibits growth, as reflected by reduced body and brain weight, length, muscle and brain protein, RNA content and brain lipid content compared with controls. This is not due to deficiency of other nutrients since control and experimental diets were identical except for NaCl content [3]. This relationship between total body sodium depletion and failure to thrive may extend well beyond the neonatal period and possibly into adulthood [4].

Hyponatremia has traditionally been attributed to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or cerebral salt wasting syndrome [5]. The syndrome of inappropriate antidiuretic hormone secretion (SIADH) should be suspected in any patient with hyponatremia, hypo-osmolality, and a urine osmolality above 100 mosmol/kg, a urine sodium concentration that is usually above 40 meq/L, with normal potassium, normal acid-base balance, and frequently low plasma uric acid concentration [6]. Feldman et al. described a SIADH-like clinical picture, which he termed Nephrogenic Syndrome of SIADH [7]. This was attributed to a mutation of the V2R gene causing constitutive activation of the receptors. This prompted us to obtain AVPR2 DNA sequence testing. The result showed an abnormal sequence of unknown clinical significance. Our patient however, does not meet the criteria for the diagnosis of SIADH. He was able to excrete free water and dilute the urine at osmolality of 58 mosmol/kg with urine sodium excretion of less than 10 mEq/L.

Reset osmostat is a rare condition in which hyponatremia occurs because of a "low set of osmostat." In this condition, the renal concentrating and diluting capacities are intact. However, the regulation of arginine vasopressin (ADH), which maintains serum tonicity, occurs at a lower osmolality threshold [8].

Patients with reset osmostat syndrome exhibit following characteristic features of the disease:

They maintain euvolemic hyponatremia with normal renal, adrenal and thyroid function.

They have no evidence of cardiac, hepatic and central nervous systems disease.

They have normal water excretion (i.e. excretion of more than 80% within 4 hours) to a standard water load (i.e. 10 to 15 mL D5W/kg given orally or intravenously).

They have intact urine diluting ability. They achieve essentially normal urine dilution after a water-loading test. (i.e. Urine osmolality less than 100 mOsm/kg)

They retain the ability to concentrate urine once the serum osmolality level is above the reset level [9].

These features constitute the diagnostic criteria of reset osmostat and our patient fulfilled all these criteria. Patients with reset osmostat who were previously described in the literature had an underlying syndrome such as a severe pulmonary [10], neurologic [11], malignancy [12] and infection [13]. Additionally, reset osmostat was reported in patients with spinal cord injury, marked psychiatric problems, alcoholism, cerebral palsy, and cleft lip or palate [14-16]. Rest osmostat in an infant with merely failure to thrive have seldom been described in literature. All reported neonates with reset osmostat however, have an underlying midline defect [17,18]. Previously reported children with reset osmostat are summarized in Table 3. Our patient has none of the above congenital defects.

Authors Gender Age at Diagnosis Physical Abnormalities Serum Na Diagnostic Studies Treatment Genetics
Banister P [6] Male 6 years Developmental delay, agenesis of corpus callosum, hypothalamic cyst, 126-128 WLT WDT Na LT Na supplement NA
Farahnak K Assadi [12] Male 8 months Cleft palate and lips 125-130 WLT WDT Na LT Na supplement NA
Thiagarajan R et al. [13] Female Newborn Midline cleft lip and palate 124-130 WDT Na LT Florinef Na supplement NA
Gupta P et al [14] Female Newborn Midline defects 129-133 Na LT Glucocorticoids Karyotype X,-X,+der(X) t(X;13) (p22.1;q22)
Ilyas et al (current case) Male 2 weeks Failure to thrive 122-133 WLT WDT Na LT Florinef Na supplement AVPR2 Sequence of unknown Significance for NDI.

Table 3: The infants with reset osmostat have been reported in literature are summarized below

Number in parenthesis ( ) indicate reference number. NA: Not Available, WLT: Water Loading Test, WDT: Water Deprivation Test; LT: Sodium loading test; NDI: Nephrogenic Diabetic Insipidus

In our patient, the mechanisms regulating the water excretion and retention appear to be intact. The kidney had a normal response to free water loading and water deprivation studies. The infant responded appropriately to water restriction, water loading, sodium restriction, sodium loading, and Fludrocortisone challenge, while maintaining serum sodium at a low set level. Water deprivation resulted in endogenous ADH release, a normal response of ADH. Water loading produced maximally diluted urine, and the administered water was properly excreted. Meanwhile, plasma ADH increased with water deprivation and fell back during water diuresis. After an infusion of hypertonic saline solution, the osmoreceptors responded appropriately by enhancing excretion of ADH, increasing urine osmolality and maintaining serum osmolality at a low set level.

The long-term outcome of infants born with reset osmostat is unknown. Our patient continues to have failure to thrive. At 24 months of age, his height and weight were still below 5th percentile. He had a normal neurological exam and had no history of seizures. The administration of high sodium supplement (~15 mEq/kg/day) was able to maintain serum sodium in the range of 130-133 mEq/L (Normal 135-150 mEq/L).

In conclusion, a six-month-old infant who presented a failure to thrive and persistent hyponatremia with normal endocrine, gastrointestinal, and neurological studies meets criteria for reset osmostat. To our knowledge, this is the only infant who has congenital reset osmostat with no associated underlying malformation or systemic disease.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 13116
  • [From(publication date):
    June-2014 - Dec 12, 2017]
  • Breakdown by view type
  • HTML page views : 9303
  • PDF downloads : 3813
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version